1 Min Read
July 11 (Reuters) - Dimerix Ltd:
* Seeks trading halt pending announcement of results from its phase 2 trial of DMX-200 in patients with chronic kidney disease Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.